Education
About Us
Working with TipRanks
Follow Us
TScan Therapeutics (TCRX)
NASDAQ:TCRX
Tsc-204-A0201, Tsc-204-C0702, Tsc-200-A0201, Tsc-204-A0201 + Tsc-204-C0702, Tsc-204-A0201 + Tsc-200-A0201, Tsc-204-C0702 + Tsc-200-A0201, Tsc-204-A0201 + Tsc-203-A0201, Tsc-204-C0702 + Tsc-203-A0201, Tsc-200-A0201 + Tsc-203-A0201, Tsc-203-A0201, Tsc-204-A0101, Tsc-201-B0702, Tsc-204-A0201 + Tsc-204-A0101, Tsc-204-A0201 + Tsc-201-B0702, Tsc-204-C0702 + Tsc-204-A0101, Tsc-204-C0702 + Tsc-201-B0702, Tsc-200-A0201 + Tsc-204-A0101, Tsc-200-A0201 + Tsc-201-B0702, Tsc-203-A0201 + Tsc-204-A0101, Tsc-203-A0201 + Tsc-201-B0702, Tsc-202-A0201, Tsc-204-A0201 + Tsc-202-A0201, Tsc-204-C0702 + Tsc-202-A0201, Tsc-200-A0201 + Tsc-202-A0201, Tsc-203-A0201 + Tsc-202-A0201, Tsc-204-A0101 + Tsc-202-A0201, Tsc-201-B0702 + Tsc-202-A0201
Cervical Cancer, Ovarian Cancer, Melanoma, Head And Neck Cancer, Hpv Positive Oropharyngeal Squamous Cell Carcinoma, Hpv-Related Cervical Carcinoma, Hpv-Related Carcinoma, Hpv-Related Anal Squamous Cell Carcinoma, Hpv-Related Penile Squamous Cell Carcinoma, Hpv-Related Vulvar Squamous Cell Carcinoma, Non-Small Cell Carcinoma, Hpv-Related Malignancy, Anogenital Cancers, Hpv - Anogenital Human Papilloma Virus Infection, Hpv-Related Squamous Cell Carcinoma, Hpv-Related Adenocarcinoma, Hpv-Related Adenosquamous Carcinoma, Hpv-Associated Vaginal Adenocarcinoma, Hpv-Related Endocervical Adenocarcinoma, Hpv-Related Verrucous Carcinoma, Hpv Positive Rectal Squamous Cell Carcinoma
Phase I
Recruiting
A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors
Jul 25, 2023
―
Control, Soc + Tsc-100, Soc + Tsc-101
Myelodysplastic Syndromes, Aml, All, Adult
Phase I
Recruiting
A Study of TSC-100 and TSC-101 in AML, ALL and MDS in Patients Undergoing Allogeneic Peripheral Blood Stem Transplantation
Jul 11, 2022
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does TScan Therapeutics (TCRX) have in its pipeline
TCRX is currently developing the following drugs: Tsc-204-A0201, Tsc-204-C0702, Tsc-200-A0201, Tsc-204-A0201 + Tsc-204-C0702, Tsc-204-A0201 + Tsc-200-A0201, Tsc-204-C0702 + Tsc-200-A0201, Tsc-204-A0201 + Tsc-203-A0201, Tsc-204-C0702 + Tsc-203-A0201, Tsc-200-A0201 + Tsc-203-A0201, Tsc-203-A0201, Tsc-204-A0101, Tsc-201-B0702, Tsc-204-A0201 + Tsc-204-A0101, Tsc-204-A0201 + Tsc-201-B0702, Tsc-204-C0702 + Tsc-204-A0101, Tsc-204-C0702 + Tsc-201-B0702, Tsc-200-A0201 + Tsc-204-A0101, Tsc-200-A0201 + Tsc-201-B0702, Tsc-203-A0201 + Tsc-204-A0101, Tsc-203-A0201 + Tsc-201-B0702, Tsc-202-A0201, Tsc-204-A0201 + Tsc-202-A0201, Tsc-204-C0702 + Tsc-202-A0201, Tsc-200-A0201 + Tsc-202-A0201, Tsc-203-A0201 + Tsc-202-A0201, Tsc-204-A0101 + Tsc-202-A0201, Tsc-201-B0702 + Tsc-202-A0201, Control, Soc + Tsc-100, Soc + Tsc-101. These drug candidates are in various stages of clinical development as the company works toward FDA approval.